Paget Bone Disease Treatment: How It Works, Results and What to Expect

Paget bone disease treatment focuses on slowing unusually rapid bone breakdown and rebuilding, most often with a bisphosphonate medicine. Many people need monitoring rather than immediate treatment, while those with symptoms, active disease or a higher risk of complications may benefit from targeted care.

Overview: how Paget bone disease treatment works

Paget bone disease treatment aims to control the accelerated cycle of bone breakdown and rebuilding that occurs in Paget’s disease of bone. The newly formed bone may become enlarged, misshapen or weaker than usual. Treatment can reduce this excessive bone activity, relieve bone pain when it is related to the condition, and lower the chance of certain complications.

The main treatment is a group of medicines called bisphosphonates. These medicines act on bone-resorbing cells, helping restore a more normal rate of bone turnover. A single intravenous treatment may provide long-lasting control for some people, while others may be offered tablets or repeat treatment depending on symptoms, test results and the bones involved.

Care is tailored rather than automatic. A person with no symptoms and low disease activity may need observation with periodic blood tests and clinical review. By contrast, treatment is commonly considered for active disease affecting weight-bearing bones, the skull or spine, or when pain, fractures, deformity, nerve compression or preparation for bone surgery are concerns.

Who may benefit from treatment and how assessment is done

Clinicians consider several factors before recommending treatment: bone pain, the site and extent of affected bone, the level of alkaline phosphatase in blood tests, imaging findings, previous fractures, mobility, hearing symptoms and plans for surgery. Alkaline phosphatase is a marker that can reflect increased bone turnover, although it may be normal when disease is limited to a small area.

Diagnosis and planning may include an X-ray of a suspected area and a bone scan to show which bones are active or involved. Blood tests help assess bone activity and check kidney function, calcium and vitamin D status before certain medicines are used. Other conditions can also cause bone pain or raised alkaline phosphatase, so interpretation is made in the context of the whole clinical picture.

Bisphosphonates may not be suitable for everyone. Kidney impairment, low calcium levels, untreated vitamin D deficiency, swallowing difficulties with oral medicines, and individual medical history can influence the choice. A clinician will also review dental health and medications because rare jaw-related complications have been associated with potent bisphosphonates, particularly in people with additional risk factors.

Treatment step by step: medicines, supportive care and surgery

Before treatment, the healthcare team confirms the diagnosis, identifies the affected bones, checks relevant blood tests and discusses treatment goals. If an intravenous bisphosphonate is chosen, it is given through a vein in a monitored outpatient setting. Oral bisphosphonates are taken on a prescribed schedule and require specific instructions to help absorption and protect the esophagus.

Zoledronic acid is often used because one infusion can produce a sustained reduction in disease activity for many people. Other bisphosphonates may be used where appropriate. Calcitonin is now used less often but can be considered if bisphosphonates cannot be used. Calcium and vitamin D may be advised when intake or blood levels are insufficient, but supplements should be personalized because they are not appropriate in every situation.

Supportive treatment may include simple pain-relief strategies, physiotherapy to preserve strength and movement, mobility aids when needed, and hearing assessment for symptoms involving the skull. Orthopedic surgery is not a treatment for the underlying bone remodeling, but it may help address a severe fracture, advanced arthritis, marked deformity or nerve compression. If surgery is planned on an affected bone, controlling high disease activity beforehand may reduce surgical bleeding risk.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can assess Paget’s disease and coordinate medical, rehabilitation and orthopedic care for international patients.

Benefits, side effects and recovery timeline

The expected benefit of bisphosphonate treatment is a fall in bone turnover markers and reduced disease activity. Bone pain may improve over weeks to months when Paget’s disease is the cause of the pain, although pain from arthritis, nerve irritation or another condition may need separate treatment. Treatment does not always reverse long-standing bone shape changes or established joint damage.

After an intravenous infusion, some people experience short-lived flu-like symptoms such as feverishness, muscle aches, headache or tiredness, usually in the first few days. Staying appropriately hydrated and following the clinician’s advice about symptom relief can help. Oral medicines may cause indigestion, nausea or irritation of the food pipe if administration instructions are not followed.

Rare but important risks include low blood calcium, kidney-related effects, inflammation in the eye, atypical thigh bone fractures with prolonged bisphosphonate exposure, and osteonecrosis of the jaw. These events are uncommon in Paget’s disease treatment, but people should report new thigh or groin pain, eye pain or redness, jaw pain, delayed healing after dental work, or symptoms of low calcium such as tingling or muscle cramps.

Follow-up often includes alkaline phosphatase testing after treatment and then at intervals decided by the clinician. Some people remain in biochemical remission for years after treatment; others may need reassessment or another course if disease activity returns. Recovery from a medicine infusion is usually brief, while recovery after orthopedic surgery depends on the procedure and rehabilitation needs.

Living with Paget's disease: practical self-care and monitoring

Regular movement, within an individual’s comfort and safety limits, can support balance, muscle strength and joint function. Low-impact activities may be particularly useful when weight-bearing bones or joints are painful. A physiotherapist can suggest exercises and safe movement adaptations for people with deformity, reduced mobility or a history of falls.

A balanced diet that provides adequate calcium and vitamin D supports general bone health. However, people should not start high-dose supplements without medical advice, especially if they have kidney disease, high calcium levels, a history of kidney stones or other health conditions. Avoiding tobacco and limiting alcohol can also support overall bone and general health.

It is helpful to tell dentists and other healthcare professionals about Paget’s disease and any bisphosphonate treatment. Routine dental care remains important. People should also keep follow-up appointments even when they feel well, because blood tests and symptom review can identify recurrent activity or complications at an early stage.

How quickly does Paget's disease of the bone progress?

Paget’s disease usually progresses slowly, often over many years, and its course varies widely between individuals. It may affect one bone or several bones, and some people never develop symptoms. In others, active remodeling gradually leads to bone enlargement, deformity, pain, arthritis near an affected joint or other complications.

The rate of progression cannot be predicted from symptoms alone. Blood markers, imaging and the location of affected bone help a clinician understand activity and risk. Effective bisphosphonate treatment can suppress excessive bone turnover, and regular follow-up helps guide whether further treatment is needed.

How long can you live with Paget disease?

Most people with Paget’s disease have a normal or near-normal life expectancy. The condition is often diagnosed later in adulthood and can remain mild, particularly when it involves a limited area and is monitored appropriately. Life expectancy is more likely to be influenced by a person’s age and other health conditions than by Paget’s disease itself.

Quality of life can be affected if there is persistent bone pain, arthritis, reduced mobility, hearing loss or fractures. Timely evaluation, symptom management and treatment of active disease can help reduce these effects. Individual outlook should be discussed with the clinician who knows the person’s affected bones, test results and overall health.

What are the stages of Paget's disease of bone? Is Paget's disease fatal? When to seek medical care

Paget’s disease is sometimes described in three phases seen in bone tissue and imaging: an early lytic phase, when bone is broken down rapidly; a mixed phase, when breakdown and new bone formation occur together; and a later sclerotic phase, when dense but structurally disorganized bone predominates. Not every affected bone follows a clearly separated sequence, and these stages are not a measure of how severe a person’s symptoms will be.

Paget’s disease itself is not usually fatal. Serious complications are uncommon but can include fractures, severe deformity, nerve compression, heart strain in very extensive active disease, and very rarely a bone cancer called osteosarcoma. New or worsening pain, especially persistent pain at night, should be assessed rather than assumed to be part of the condition.

Medical care should be sought for new bone pain, a change in bone shape, reduced hearing, numbness or weakness, difficulty walking, a fracture after a minor injury, or a new severe headache when skull involvement is known or suspected. Urgent assessment is appropriate for sudden weakness, loss of bladder or bowel control, severe back pain with neurologic symptoms, or signs of a fracture. A qualified doctor can determine whether symptoms are due to Paget’s disease or another cause.

Frequently asked questions

What is the most effective Paget bone disease treatment?

Bisphosphonates are the main and most effective medicines for reducing the high bone turnover of Paget's disease. Zoledronic acid given intravenously is commonly used because it can provide prolonged disease control. The best option depends on kidney function, calcium and vitamin D levels, symptoms and individual medical history.

Does everyone with Paget's disease need treatment?

No. Some people have no symptoms, limited disease activity and a low risk of complications, so monitoring may be appropriate. Treatment is more often recommended for active disease in certain bones, Paget-related bone pain, complications, or before surgery involving affected bone.

Can Paget's disease go away after treatment?

Treatment can suppress the excessive bone activity for a long time, sometimes for years, but it does not remove the underlying tendency to Paget's disease. Blood markers may return to normal and symptoms may improve. Periodic follow-up is still important because activity can recur.

How soon will pain improve after a bisphosphonate infusion?

If pain is caused by active Paget's disease, improvement may begin over several weeks and continue over subsequent months. Not all pain in an affected area is caused by Paget's disease; arthritis, nerve compression or other conditions may also contribute. A clinician can reassess persistent pain and adjust care accordingly.

Can Paget's disease cause cancer?

A cancerous change in Paget-affected bone, usually osteosarcoma, is very rare. New, persistent or rapidly worsening bone pain, swelling, or pain that is particularly noticeable at night should be evaluated promptly. Most people with Paget's disease will never develop this complication.

What follow-up is needed after Paget bone disease treatment?

Follow-up commonly includes blood tests such as alkaline phosphatase to assess whether bone turnover has reduced and remains controlled. The timing of testing varies according to the medicine used, disease extent and previous results. Imaging may be repeated if symptoms change or if a clinician needs to evaluate a specific bone.

References

• National Institute of Arthritis and Musculoskeletal and Skin Diseases
• NHS
• Mayo Clinic
• International Osteoporosis Foundation
• Merck Manual Consumer Version

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.